NCT05673369View on ClinicalTrials.gov

Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

February 11, 2023

Study Completion Date

February 27, 2023

Conditions
Endocrine, Nutritional and Metabolic Diseases
Interventions
DRUG

CKD-387

1 Tablet

DRUG

D484

1 Tablet

Trial Locations (1)

Unknown

Bumin Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY